<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/23448F65-90C6-4DC2-875E-B13FFE28CBD1"><gtr:id>23448F65-90C6-4DC2-875E-B13FFE28CBD1</gtr:id><gtr:name>Biotectix</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/23448F65-90C6-4DC2-875E-B13FFE28CBD1"><gtr:id>23448F65-90C6-4DC2-875E-B13FFE28CBD1</gtr:id><gtr:name>Biotectix</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3C738BD9-4710-4E67-9D32-EB35F8CF7C88"><gtr:id>3C738BD9-4710-4E67-9D32-EB35F8CF7C88</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Pickett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FE526007%2F1"><gtr:id>25AD45F9-1FA0-414D-880A-735578D8AEB8</gtr:id><gtr:title>In Vitro Biocompatibility and Release Characteristics of Polypyrrole-bupivacaine Coatings for Neurostimulators</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E526007/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>87961</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotectix</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Chameleon Biosurfaces Ltd</gtr:description><gtr:id>F7865B73-F9A1-47D2-A9EF-87D5E1021975</gtr:id><gtr:impact>Patents.</gtr:impact><gtr:partnerContribution>Characterisation of biophysical properties.</gtr:partnerContribution><gtr:piContribution>Synthesis and electropolymerisation of monomers</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Patents and know how arising in part from Follow on Fund work purchased by US biomed company.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>FE22DC21-6AA5-45D3-A56E-A899E2C10C3D</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This patent application covers applications of electropolymers for heart stimulation applications.</gtr:description><gtr:id>D31CC612-29CC-4B5A-BA47-CE32D4969477</gtr:id><gtr:impact>Patent transferred to US biomedical company. Impact unknown.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>UK patent application 1012808.0 (Submitted: 2010)  US patent: Implantable Electrode US 2012/0029585 (publication date: 2012)</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Coating on titanium nitride</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>This patent describes low thrombogenicity electropolymer materials including their preparation and biophysical characterisation.</gtr:description><gtr:id>39FE0C25-4675-43EE-992B-33D99CD42EB0</gtr:id><gtr:impact>Patent transferred to US biomedical company. Commercial developments unknown.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>EP2155275(A2)</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Polymer coatings on medical devices</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>New electropolmeric systems developed which can incorporate deliverable drugs. Emphasis of Follow-on-Fund grant shifted to new coatings for stents and, in conjuction with certain biomedical companies, neural stimulators.</gtr:description><gtr:exploitationPathways>Patents and Know how arising in part from this study were purchased by US biomedical company in 2011.</gtr:exploitationPathways><gtr:id>B18A93DD-634B-4DB3-8D8B-64A23134B985</gtr:id><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/E526007/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>